Erythrocyte sedimentation rate
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
The erythrocyte sedimentation rate (ESR), also called a sedimentation rate, sed rate or 'Biernacki Reaction', is a non-specific measure of inflammation that is commonly used as a medical screening test.
To perform the test, anticoagulated blood is placed in an upright tube, known as a Westergren tube and the rate at which the red blood cells fall is measured and reported in mm/h.
When an inflammatory process is present, the high proportion of fibrinogen in the blood causes red blood cells to stick to each other. The red cells form stacks called 'rouleaux' which settle faster. Rouleau formation can also occur in association with some lymphoproliferative disorders in which one or more immunoglobulins are secreted in high amounts. Rouleau formation is however a physiological finding in some equidae and can be as such in felidae and suidae species, namely the horse, cat and pig respectively.
The ESR is increased by any cause or focus of inflammation. The ESR is decreased in sickle cell anemia, polycythemia, and congestive heart failure. The basal ESR is slightly higher in females.
History
This test was invented in 1897 by the Polish doctor Edmund Biernacki.[1] In 1918 the Swedish pathologist Robert Sanno Fåhræus declared the same and along with Alf Vilhelm Albertsson Westergren are eponymously remembered for the Fåhræus-Westergren test (in the UK, usually termed Westergren test),[1] which uses sodium citrate-anticoagulated specimens.[1]
Uses
Although it is frequently ordered, the erythrocyte sedimentation rate (ESR) is not a useful screening test. It is only useful for diagnosing three diseases: myeloma, temporal arteritis and polymyalgia rheumatica (in which it may exceed 100 mm/hour).
It is commonly used for a differential diagnosis for Kawasaki's Disease and it may be increased in some chronic infective conditions like tuberculosis and infective endocarditis. It is a component of the PDCAI, an index for assessment of severity of inflammatory bowel disease in children.
The clinical usefulness of erythrocyte sedimentation rate (ESR) is limited to monitoring the response to therapy in certain inflammatory diseases such as temporal arteritis, polymyalgia rheumatica and rheumatoid arthritis. It can also be used as a crude measure of response in Hodgkin's lymphoma. Additionally, ESR levels are used to define one of the several possible "adverse prognostic factors" in the staging of Hodgkin's lymphoma.
The use of the ESR as a screening test in asymptomatic persons is limited by its low sensitivity and specificity. When there is a moderate suspicion of disease, the ESR may have some value as a "sickness index."
An elevated ESR in the absence of other findings should NOT trigger an extensive laboratory or radiographic evaluation.
Normal Values
Note: mm/hr. = millimeters per hour.
Values are increased in states of anemia,[1] and in black populations.[1]
Adults
ESR reference ranges from a large study:[1]
| (ESR 95% limits) | Age (years) | ||
| 20 | 55 | 90 | |
|---|---|---|---|
| Men | 12 | 14 | 19 |
| Women | 18 | 21 | 23 |
As an alternative the following formula may be used to give predicted values for ESR based on age and gender:[1]
Children
- Newborn: 0 to 2 mm/hr.
- Neonatal to puberty: 3 to 13 mm/hr.
- Newborn: 0-5 mm/hr.
- Neonatal to puberty: 0-15 mm/hr.
Differential Diagnosis
Decreased
- Afibrinogenemia
- Cryoglobulinemia
- Drugs
- Hypofibrinogenemia
- Macroglobulinemia
- Polycythemia Vera
- Sickle cell Disease
- Spherocytosis
Increased
- Acanthocytosis
- Acute glomerulonephritis
- Acute liver failure
- Acute pancreatitis
- Bacterial infection
- Burn injury
- Cat Scratch Disease
- Cholecystitis
- Chronic granulomatous disease
- Dermatomyositis
- Drugs
- Heart failure
- Hemolytic anemia
- Hemolytic Uremic Syndrome (HUS)
- Henoch-Schonlein Purpura
- Hodgkin's Lymphoma
- Hyperfibrinogenemia
- Hypothyroidism
- Infantile cortical hyperostosis
- Infectious hepatitis
- Inflammatory Bowel Disease
- Iron deficiency anemia
- Leptospirosis
- Leukemia
- Lupoid hepatitis
- Macroglobulinemia
- Familial Mediterranean Fever
- Metastases
- Multiple Myeloma
- Nephrosis
- Non-Hodgkin's Lymphoma
- Peritonitis
- Poikilocytosis
- Polymyalgia Rheumatica
- Pregnancy
- Pneumonia
- Pyelonephritis
- Rheumatoid Arthritis
- Rheumatic Fever
- Sarcoidosis
- Scleroderma
- Secondary syphilis
- Sickle Cell Anemia
- Surgery
- Systemic fungal infection
- Systemic Lupus Erythematosus
- Temporal arteritis
- Thyroiditis
- Tuberculosis
- Vasculitis
- Viral infection
- Vitamin B12 Deficiency anemia [1] [1]
References
Acknowledgements
The content on this page was first contributed by Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3] Phone:617-525-6884
de:Blutsenkungsreaktion fr:Vitesse de sédimentation it:Velocità di eritrosedimentazione he:שקיעת דם lt:Eritrocitų nusėdimo greitis nl:Bezinkingssnelheid van de erythrocyten ja:赤血球沈降速度 no:Senkningsreaksjonfi:Lasko sv:Sänkningsreaktion
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
